{"hands_on_practices": [{"introduction": "To begin, we focus on the primary function of the citric acid cycle: the generation of high-energy electron carriers. This fundamental practice challenges you to perform the essential \"biochemical bookkeeping\" for the complete oxidation of pyruvate, tallying the net yield of NADH, $\\text{FADH}_2$, and GTP. Mastering this calculation is the first step toward appreciating the cycle's massive contribution to cellular energy production. [@problem_id:2081638]", "problem": "A biochemist is investigating cellular respiration in an isolated mitochondrial preparation. The experiment is designed to trace the metabolic fate of pyruvate that is directly transported into the mitochondrial matrix, thus bypassing all glycolytic steps. The goal is to quantify the production of key energy-carrying molecules generated from the complete oxidation of this pyruvate.\n\nConsidering the entire pathway starting from a single molecule of pyruvate, determine the net number of molecules of Nicotinamide Adenine Dinucleotide (NADH) in its reduced form, Flavin Adenine Dinucleotide ($\\text{FADH}_2$) in its reduced form, and Guanosine Triphosphate (GTP) that are produced. The process encompasses the reaction catalyzed by the Pyruvate Dehydrogenase Complex (PDC) and one subsequent, complete turn of the citric acid cycle (also known as the Krebs cycle).\n\nPresent your answer as a row matrix with three entries corresponding to the net yield of NADH, $\\text{FADH}_2$, and GTP, in that specific order.", "solution": "We consider a single molecule of pyruvate already in the mitochondrial matrix, so no glycolytic yields are counted. The net yield sought includes the pyruvate dehydrogenase complex (PDC) and one complete turn of the citric acid cycle (Krebs cycle) driven by the resulting acetyl-CoA.\n\nFirst, the PDC reaction converts pyruvate to acetyl-CoA, producing one reduced nicotinamide adenine dinucleotide:\n$$\\text{Pyruvate} + \\text{CoA-SH} + \\text{NAD}^{+} \\rightarrow \\text{Acetyl-CoA} + \\text{CO}_{2} + \\text{NADH} + \\text{H}^{+}.$$\nFrom this step per pyruvate: NADH yield is $1$, and there is no $\\text{FADH}_{2}$ or GTP produced.\n\nSecond, one acetyl-CoA enters the citric acid cycle and, over one complete turn, the net redox and substrate-level phosphorylation yields are:\n$$\\text{Acetyl-CoA} + 3\\,\\text{NAD}^{+} + \\text{FAD} + \\text{GDP} + P_{i} + 2\\,\\text{H}_{2}\\text{O} \\rightarrow 2\\,\\text{CO}_{2} + 3\\,\\text{NADH} + 3\\,\\text{H}^{+} + \\text{FADH}_{2} + \\text{GTP} + \\text{CoA-SH}.$$\nFrom this step per acetyl-CoA (and hence per starting pyruvate): NADH yield is $3$, $\\text{FADH}_{2}$ yield is $1$, and GTP yield is $1$.\n\nSumming the contributions from PDC and the citric acid cycle for one starting pyruvate gives the net yields:\n- NADH: $1$ (PDC) $+\\,3$ (TCA) $= 4$,\n- $\\text{FADH}_{2}$: $0$ (PDC) $+\\,1$ (TCA) $= 1$,\n- GTP: $0$ (PDC) $+\\,1$ (TCA) $= 1$.\n\nTherefore, the row matrix in the order NADH, $\\text{FADH}_{2}$, GTP is $\\begin{pmatrix}4 & 1 & 1\\end{pmatrix}$.", "answer": "$$\\boxed{\\begin{pmatrix}4 & 1 & 1\\end{pmatrix}}$$", "id": "2081638"}, {"introduction": "Metabolic pathways are not just sequences of reactions; they are dynamic systems susceptible to regulation and inhibition. This problem explores this concept through a classic experimental scenario involving the inhibitor malonate. By analyzing its effect on oxygen consumption, you will connect the principles of competitive enzyme inhibition to a specific reaction within the citric acid cycle, deepening your understanding of how molecular structure dictates function and can be used to probe metabolic flux. [@problem_id:2081683]", "problem": "In a biochemistry laboratory experiment, isolated mitochondria are suspended in a buffered solution containing an adequate supply of Adenosine Diphosphate (ADP) and inorganic phosphate. The addition of succinate, a four-carbon dicarboxylate, to this suspension results in a steady and measurable rate of oxygen consumption. Subsequently, a compound called malonate, which is a three-carbon dicarboxylate, is introduced into the active mitochondrial suspension. The addition of malonate is observed to cause a significant decrease in the rate of oxygen consumption. Which of the following statements provides the most accurate biochemical explanation for the inhibitory effect of malonate in this experimental system?\n\nA. Malonate acts as an allosteric inhibitor, binding to a regulatory site on the succinate dehydrogenase enzyme distinct from the active site, which induces a conformational change that reduces the enzyme's catalytic efficiency.\nB. Malonate functions as a competitive inhibitor because its molecular structure is a close analog to that of the substrate succinate, allowing it to reversibly bind to the active site of succinate dehydrogenase but not undergo the catalytic reaction.\nC. Malonate acts as an uncoupler of oxidative phosphorylation by inserting into the inner mitochondrial membrane and dissipating the proton motive force, which increases the rate of electron transport but halts ATP synthesis.\nD. Malonate is a noncompetitive inhibitor that binds with equal affinity to both the free succinate dehydrogenase enzyme and the enzyme-substrate complex at a site other than the active site, thereby lowering the maximum velocity of the reaction.\nE. Malonate acts as an irreversible inhibitor, forming a stable covalent bond with the Flavin Adenine Dinucleotide (FAD) cofactor within the active site of succinate dehydrogenase, leading to permanent inactivation of the enzyme.", "solution": "The experimental system contains isolated mitochondria with ADP and inorganic phosphate, so oxygen consumption reflects electron transport coupled to oxidative phosphorylation. Addition of succinate increases oxygen consumption because succinate is oxidized to fumarate by succinate dehydrogenase (Complex II), reducing FAD to $\\text{FADH}_{2}$, and passing electrons to ubiquinone and ultimately to oxygen at Complex IV. Therefore, the rate of oxygen consumption is proportional to the flux through succinate dehydrogenase.\n\nMalonate is a classic structural analog of succinate (both are dicarboxylates, with malonate lacking one methylene group relative to succinate), and it binds to the active site of succinate dehydrogenase without undergoing oxidation. This is the defining feature of competitive inhibition.\n\nFor an enzyme following Michaelis–Menten kinetics, the uninhibited rate is\n$$\nv=\\frac{V_{\\max}[S]}{K_{m}+[S]},\n$$\nwhile in the presence of a competitive inhibitor at concentration $[I]$ with inhibition constant $K_{i}$, the rate becomes\n$$\nv=\\frac{V_{\\max}[S]}{K_{m}\\left(1+\\frac{[I]}{K_{i}}\\right)+[S]}.\n$$\nAt fixed $[S]$, the denominator increases by a factor of $1 + \\frac{[I]}{K_i}$, so $v$ decreases, matching the observed decrease in oxygen consumption upon adding malonate. Importantly, $V_{\\max}$ is unchanged in competitive inhibition, and the inhibition can be overcome by increasing $[S]$, consistent with malonate’s behavior.\n\nAlternative choices are inconsistent with known properties and the observation:\n- An uncoupler would increase the rate of electron transport and thus oxygen consumption by dissipating the proton gradient, contrary to the observed decrease; therefore C is incorrect.\n- Noncompetitive inhibition lowers $V_{\\max}$ by binding to both $E$ and $ES$ at a site distinct from the active site and does not depend on substrate structural similarity; malonate’s well-established mechanism is not noncompetitive, so D is incorrect.\n- Allosteric inhibition (A) would not require structural mimicry of succinate and is not the recognized mechanism for malonate with succinate dehydrogenase.\n- Irreversible covalent modification of FAD (E) does not occur with malonate; its inhibition is reversible and relieved by higher succinate.\n\nTherefore, malonate functions as a competitive inhibitor of succinate dehydrogenase due to its structural similarity to succinate, binding the active site without being oxidized.", "answer": "$$\\boxed{B}$$", "id": "2081683"}, {"introduction": "A true understanding of a metabolic pathway comes from being able to trace the journey of individual atoms through its intricate series of transformations. This advanced exercise uses isotopic labeling to follow the carbon atoms from acetyl-CoA through one full turn of the cycle. This practice reveals the non-intuitive fate of these carbons, emphasizing the importance of molecular symmetry and the stereospecific nature of the cycle's enzymes, and proves that the carbons released as $\\text{CO}_2$ in the first turn are not the ones that just entered. [@problem_id:2081662]", "problem": "In a biochemical investigation, a sample of isolated and actively respiring mitochondria is provided with all necessary substrates for the citric acid cycle. The cycle is initiated by supplying acetyl-CoA that has been isotopically labeled with carbon-14 ($^{14}\\text{C}$) specifically at its methyl carbon. The other substrate, oxaloacetate, is unlabeled. The system is allowed to proceed through exactly one complete turn of the citric acid cycle, starting with the condensation of the labeled acetyl-CoA with oxaloacetate and ending with the regeneration of one molecule of oxaloacetate. For the purpose of this problem, use the standard chemical numbering for oxaloacetate, where C1 is the carbon of the carboxyl group adjacent to the keto group, C2 is the keto-carbon, C3 is the methylene carbon, and C4 is the carbon of the terminal carboxyl group (HOOC(4)-CH2(3)-C(=O)(2)-COOH(1)).\n\nWhich of the following statements accurately describes the fate of the $^{14}\\text{C}$ label at the conclusion of this single turn?\n\nA. The $^{14}\\text{C}$ will have been released as $^{14}\\text{CO}_2$ in the decarboxylation step catalyzed by isocitrate dehydrogenase.\nB. The $^{14}\\text{C}$ will have been released as $^{14}\\text{CO}_2$ in the decarboxylation step catalyzed by the α-ketoglutarate dehydrogenase complex.\nC. The $^{14}\\text{C}$ will be found exclusively in the C4 position (terminal carboxyl group) of the regenerated oxaloacetate.\nD. The $^{14}\\text{C}$ will be equally distributed between the C2 (keto-carbon) and C3 (methylene carbon) positions of the regenerated oxaloacetate.\nE. The $^{14}\\text{C}$ will be found exclusively in the C2 position (keto-carbon) of the regenerated oxaloacetate.", "solution": "We are given acetyl-CoA labeled at its methyl carbon (the acetyl C2) and unlabeled oxaloacetate (OAA) with the specified numbering: OAA C1 is the carboxyl carbon adjacent to the keto group, OAA C2 is the keto carbon, OAA C3 is the methylene carbon, and OAA C4 is the terminal carboxyl carbon.\n\nStep 1: Citrate synthase forms citrate by condensation of the enol(ate) of acetyl-CoA with the carbonyl carbon (OAA C2). The new C–C bond is formed between the acetyl methyl carbon (labeled acetyl C2) and OAA C2. No carbons are lost; this step only reorganizes bonding. Thus, both acetyl carbons enter the six-carbon citrate skeleton distinctly labeled by origin.\n\nStep 2: Aconitase isomerizes citrate to isocitrate via cis-aconitate without carbon loss. Carbon positions are conserved with respect to origin; no decarboxylation occurs here.\n\nStep 3: Isocitrate dehydrogenase catalyzes oxidative decarboxylation of isocitrate to alpha-ketoglutarate with release of one $\\text{CO}_{2}$. The carbon released at this stage in the first turn is derived from the original OAA, not from acetyl-CoA. This is a standard consequence of the mapping of carbons in the tricarboxylic acid: in the first turn, neither of the two acetyl-derived carbons is released as $\\text{CO}_{2}$. Therefore, statement A is false for the first turn.\n\nStep 4: The alpha-ketoglutarate dehydrogenase complex catalyzes a second oxidative decarboxylation to succinyl-CoA with release of another $\\text{CO}_{2}$. In the first turn, this $\\text{CO}_{2}$ is also derived from OAA, not from acetyl-CoA. Thus, statement B is false for the first turn.\n\nStep 5: The two acetyl-derived carbons persist into succinyl-CoA and then succinate. At the succinate stage, the two carbons originating from acetyl-CoA occupy the two equivalent inner methylene positions of succinate (succinate C2 and C3). Because succinate is a symmetric molecule, these two positions are chemically equivalent.\n\nStep 6: Conversion of succinate to fumarate (succinate dehydrogenase) and hydration to malate (fumarase) are stereospecific transformations, but the symmetry of succinate permits binding in two orientations that are related by a 180-degree rotation. As a result, across a population of molecules, the single labeled acetyl methyl carbon is carried with equal probability into either the C2 or the C3 position of malate. Malate dehydrogenase then oxidizes malate at C2 to regenerate OAA, placing the label at OAA C2 if it was at malate C2, or at OAA C3 if it was at malate C3. Because of the prior symmetry and the equal likelihood of the two binding orientations, the label is equally distributed between OAA C2 (keto carbon) and OAA C3 (methylene carbon) after exactly one turn.\n\nStep 7: Therefore:\n- The label is not released as $\\text{CO}_{2}$ at either decarboxylation in the first turn (rules out A and B).\n- It is not found exclusively at OAA C4 (rules out C).\n- It is not found exclusively at OAA C2 (rules out E).\n- It is equally distributed between OAA C2 and C3 (supports D).\n\nHence, the correct statement is D.", "answer": "$$\\boxed{D}$$", "id": "2081662"}]}